Brickell Biotech, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Miami FL United States (2009)
Status: Acquired by Vical (2019)

Organization Overview

First Clinical Trial
2014
NCT02058264
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Mergers & Acquisitions

Historical Acquisition Tree